Before you invest in a GRAS notice. SciBridge turns the FDA's own GRAS record into structured, searchable data, and lets you screen a candidate ingredient against real precedent to evaluate substantial similarity and produce a downloadable, defensible report.
SciBridge is SciPinion's ingredient screening platform, built on the FDA's own GRAS record — the notices the agency responded to with "no questions." Structured field by field, and kept in step with the record as it changes.
Three short walkthroughs for navigating the early access trial: search the record, screen a candidate, and take an evaluation all the way to a report.
The evaluation is only as strong as what it stands on — so every layer is built to be checked.
Every comparison is grounded in notices FDA has already reviewed with "no questions," not model opinion.
Every extracted value traces to its source page, so the report stands up to scrutiny.
Screening a company runs itself, in-house, on its own timeline.
From an open search of the GRAS record to a complete substantial-similarity evaluation, each tool builds on the one before it.
Search the FDA GRAS database with extracted scientific data.
Select GRNs and view their fields side by side.
Track recent GRAS activity, new notices and status changes, flagged nightly.
Upload a fact sheet; surface the GRNs your ingredient is most similar to.
Upload a full dossier and complete a substantial-similarity evaluation with a downloadable report.
Customized license access to the tools you need, from GRAS database search to full substantial-similarity reporting. Choose the plan that fits your volume, and scale up as your needs grow.
View plans →SciPinion-led engagements: gaps analysis, dossier development, and optional independent expert-panel validation, the modified Delphi process wrapped around a Bridge evaluation.
Start a conversation →Screen a candidate against real GRAS precedent, or ask us to walk you through it.